Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about pending Supreme Court cases focused on intellectual property; and
- another article about “the five most important developments” in 2022 related to “patents in the pharma and biotech sectors.”
Scott Graham authored an article for Law.com about pending Supreme Court cases focused on intellectual property. Graham reported how the Supreme Court “is expected to hear arguments in a high-stakes biopharma patent case and two trademark cases” after “a few relatively quiet years for IP.” Graham noted how other developments could involve “how litigation over COVID vaccines will play out” as well as “new patent eligibility guidance.”
Adam Houldsworth wrote an article for IAM about “the five most important developments” covered by IAM in 2022 related to “patents in the pharma and biotech sectors.” These developments include Supreme Court, China, and World Trade Organization activity as well as activity related to mRNA patents and CRISPR technologies.